Results 171 to 180 of about 486,983 (268)

Analysis of the Role of the SRC Tyrosine Kinase and Podoplanin in the Process of Entosis. [PDF]

Cancers (Basel)
Gawel AM, Godlewska M, Biały LP, Mlynarczuk-Bialy I.   +3 more
europepmc   +1 more source

Targeting NRP1 in Endothelial Cells Facilitates the Normalization of Scar Vessels and Prevents Fibrotic Scarring

Advanced Science, EarlyView.
Scars exhibit vascular abnormal alterations, including upregulated NRP1 expression in endothelial cells, increased vascular density and branching, compromised vessel wall integrity, and incomplete pericyte coverage. Therapeutic targeting of NRP1 through hydrogel spray delivery offers a promising approach to normalize aberrant vasculature and prevent ...
Yu Wang, Xin Zhou, Min Liu, Meimei Huang, Peirong Chen, Xinying Li, Fangchao Xue, Wenyan Zhao, Di Liu, Lang Li, Yuangang Lu, Wen Zeng   +11 more
wiley   +1 more source

Bone Marrow Edema and Tyrosine Kinase Inhibitors Treatment in Chronic Myeloid Leukemia. [PDF]

Diagnostics (Basel)
Russo S, Fazio M, Mirabile G, Sciaccotta R, Stagno F, Allegra A.   +5 more
europepmc   +1 more source

Modulation of K_V1.3 channels by protein kinase A I in T lymphocytes is mediated by the disc large 1-tyrosine kinase Lck complex

, 2012
Zerrin Kuras, Vladimir Kucher, Scott M. Gordon, Lisa Neumeier, Ameet A. Chimote, Alexandra H. Filipovich, Laura Conforti   +6 more
openalex   +2 more sources

Etk/Bmx Tyrosine Kinase Activates Pak1 and Regulates Tumorigenicity of Breast Cancer Cells [PDF]

, 2001
Rozita Bagheri‐Yarmand, Mahitosh Mandal, Amjad H. Taludker, Rui‐An Wang, Ratna K. Vadlamudi, Hsing-Jien Kung, Rakesh Kumar   +6 more
openalex   +1 more source

PARPi Combining Nanoparticle LIN28B siRNA for the Management of Malignant Ascites

Advanced Science, EarlyView.
This study demonstrates that co‐inhibition of LIN28B and PARP using siLin28b/DSSP@lip‐PEG‐FA nanoparticles in combination with the PARP inhibitor BMN673 effectively suppresses the accumulation of malignant ascites associated with advanced cancers.
Yan Fang, Qian Shen, Yao Lin, Jing Zhu, Xiaolan Zhu, Rui Huang, Yijia Wu, Feiyang Shen, Qian Li, Guopei Zheng, Zhe Zhang, Qian Chu, Junhao Hu, Jianfeng Shen   +13 more
wiley   +1 more source

Cryptococcal Infection in a Patient With Chronic Lymphocytic Leukaemia Receiving Acalabrutinib, a Bruton's Tyrosine Kinase Inhibitor: A Case Report. [PDF]

Cureus
Al-Shaker AN, Agarwal A, Saeed MT, Marney Z.   +3 more
europepmc   +1 more source

Long-term outcome of neoadjuvant tyrosine kinase inhibitors (TKI) in locally advanced dermatofibrosarcoma protuberans (DFSP)

, 2019
J. Beaziz, Maxime Battistella, Julie Delyon, Christine Le Maignan, O. Marco, Delphine Kérob, Camille Laurent, Laetitia Da Meda, C. Farges, Nicole Basset‐Séguin, Célèste Lebbé, Barouyr Baroudjian   +11 more
openalex   +1 more source

Phosphorylation- and Activation-independent Association of the Tyrosine Kinase Syk and the Tyrosine Kinase Substrates Cbl and Vav with Tubulin in B-Cells [PDF]

, 1999
José A. Fernández, Lakhu Keshvara, Jennifer D. Peters, Michael Furlong, Marietta L. Harrison, Robert L. Geahlen   +5 more
openalex   +1 more source

CD168 Identifies Proliferating Pancreatic Islet Cells in Murine and Human

Advanced Science, EarlyView.
This study identifies CD168 as a conserved surface marker for proliferating β‐cells in mouse, human islets, and pancreatic islet tumors. CD168⁺ cells show high proliferation and low insulin expression. CD168+ cells form mostly uni‐β lineage clones, and some of the clones are multi‐lineage.
Shubo Yuan, Jiafu Li, Min Shao, Haili Bao, Ajun Geng, Jialin Yang, Yu Tao, Xinyi Chen, Tianxiong Xiao, Chunye Liu, Zhiyao Xie, Wenqian Song, Qing Cissy Yu, Hongxing Fu, Xu Han, Taochen He, Wenquan Wang, Jianfeng Chen, Sheng Yan, Shaohua Song, Liang Liu, Yi Arial Zeng   +21 more
wiley   +1 more source